Is your mast cell disorder genetic?

If you live with a mast cell disorder, at some point you've probably asked one of these questions: Did I inherit this? Could I pass it to my kids? Should my family members get tested?

These are some of the most common questions we hear from the mast cell community, and the honest answer is: it depends on which mast cell disorder you have.

The word "genetic" means something different for each one, and mixing them up causes a lot of unnecessary worry (and sometimes, missed answers). Let's sort it out.

First, definitions of mast cell disorders

"Mast cell disorder" is an umbrella that covers a few distinct conditions:

• Mastocytosis, where the body makes too many mast cells. It can affect mostly the skin (cutaneous mastocytosis, more common in children) or internal organs and bone marrow (systemic mastocytosis, more common in adults).

• Mast cell activation syndrome (MCAS), where mast cell numbers are normal but the cells release their chemical contents too easily.

• Hereditary alpha-tryptasemia (HaT), a genetic trait where extra copies of a tryptase gene lead to elevated baseline tryptase levels and, in some people, mast cell type symptoms.

  
  

Each of these has a different relationship with your DNA.

Mastocytosis: genetic, but usually not inherited

Here's a distinction that surprises almost everyone: a condition can be caused by a gene change and still not run in families.

About 90 percent of systemic mastocytosis cases are linked to a change in a gene called KIT. The most common one, known as D816V, is found in more than 80 percent of adults with SM. It acts like a stuck accelerator: KIT normally tells mast cells when to grow, and this change leaves the signal switched on.

Here's the key part: this KIT change is almost always somatic, meaning it arose in a group of cells after conception rather than being passed down from a parent. It lives in the affected mast cells, not in the DNA you inherited or the DNA you pass on. That's why the vast majority of SM is sporadic, occurring in people with no family history at all.

In practice, that means: if you have systemic mastocytosis, your children and siblings are not expected to have a meaningfully increased risk.

Familial mastocytosis has been documented, but it is genuinely rare, and in those exceptional families the condition follows a dominant pattern (a 50 percent chance for each child). So if multiple relatives in your family have actually been diagnosed with mastocytosis, that's the uncommon situation where a closer genetic evaluation is warranted.

For everyone else, one of the most valuable things we can offer in our practice is often relief: there is no cascade of testing that relatives need to pursue.

One more distinction worth knowing, especially for anyone with an advanced form of SM: doctors sometimes test the mastocytosis cells themselves for additional acquired gene changes (with names like TET2, SRSF2, and ASXL1), because those findings can shape prognosis and treatment choices. That's molecular profiling of the disease, not genetic testing of you, and it has no implications for your family members. Patients understandably conflate the two, and knowing the difference can save you a lot of worry in the hematologist's office.

MCAS: no single gene, but families notice patterns

MCAS does not have a single known genetic cause, and it is not considered a directly inherited condition. There is no gene test that diagnoses it. But that doesn't mean genetics is irrelevant, because MCAS keeps company with conditions that are.

If you have hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorder, you may already know this pattern firsthand. Many patients in the hypermobility community carry a trio of diagnoses: a connective tissue disorder, a form of dysautonomia such as POTS, and mast cell activation symptoms. This clustering is well described in the literature and clinically familiar to those of us who work in this space, and it's common enough that some clinicians treat the presence of one as a reason to look for the others.

Why they travel together isn't fully settled. Mast cells live in connective tissue, so it's plausible that altered connective tissue changes the environment those cells operate in. The chemicals mast cells release can also affect blood vessel tone and tissue remodeling, which may feed back into both hypermobility symptoms and orthostatic intolerance. There may also be shared underlying factors we haven't identified yet. What we can say honestly is that the association is real and the mechanism is still being worked out.

Here's what that means practically. Hypermobile EDS is currently a clinical diagnosis, with no confirmed genetic test, so genetic testing in this situation isn't about proving hEDS. Its role is different, and still valuable: ruling out other heritable connective tissue disorders that can look similar but carry different medical risks, such as vascular EDS, classical EDS, Marfan syndrome, and Loeys-Dietz syndrome. Some of those come with vascular or aortic concerns that genuinely change monitoring, and for those, family testing matters. Sorting out whether your hypermobility is hEDS or something else is one of the most consequential questions we help patients answer.

So if you're navigating the hypermobility, dysautonomia, and mast cell trio, the productive genetics question usually isn't "which gene causes my MCAS?" It's "is there a heritable connective tissue disorder in this picture, and does anyone in my family need to know?"

Many patients also tell us that reactive, allergic-type symptoms seem to cluster in their family, and they're not imagining it. Some of that may be shared environment, some may be traits we don't yet understand, and some, importantly, may be explained by the next condition on the list.

HaT: the one that actually runs in families

Hereditary alpha-tryptasemia is the true "family" member of this group. People with HaT carry extra copies of the TPSAB1 gene, which raises baseline tryptase levels. It's inherited in a dominant pattern, meaning each child of a person with HaT has a 50 percent chance of inheriting it. Research suggests roughly 1 in 20 people carry it, most without knowing.

HaT matters for two reasons. First, it can explain a persistently elevated tryptase that otherwise sends patients on a years-long diagnostic odyssey. Second, when HaT coexists with another mast cell disorder, reactions may be more severe, which can change what precautions make sense.

If elevated tryptase or unexplained flushing, GI symptoms, or reactions seem to run in your family, HaT is worth asking about. It's diagnosed with a specific test called tryptase genotyping, which is not part of standard genetic panels and has to be deliberately ordered.

So... should your family members be tested?

It depends on your diagnosis:

• Systemic mastocytosis: usually no family testing needed, because the KIT change is somatic. A genetic counselor can confirm whether your situation fits the typical pattern.

• MCAS: there's no gene test to offer relatives, but a careful family history can reveal whether something else (like HaT or a connective tissue disorder) is hiding in the picture.

• HaT: first-degree relatives each have a 50 percent chance of carrying it, so testing can be genuinely informative, especially for relatives with symptoms or unexplained labs.

  
  

Where genetic counseling fits

Sorting out which of these situations applies to you is exactly what genetic counseling is for. We review your labs (including that tryptase level), your symptoms, and your family history, then help you figure out which testing, if any, would actually change something for you or your relatives. No referral needed, and everything happens by telehealth.

Wondering what your mast cell disorder means for your family? Book a free 10-minute discovery call at empowergeneticshealth.com/book and let's talk it through.

This post is for educational purposes and is not a substitute for personalized medical advice.